These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22977012)

  • 21. Synthesis and Evaluation of PPARδ Agonists That Promote Osteogenesis in a Human Mesenchymal Stem Cell Culture and in a Mouse Model of Human Osteoporosis.
    Kress BJ; Kim DH; Mayo JR; Farris JT; Heck B; Sarver JG; Andy D; Trendel JA; Heck BE; Erhardt PW
    J Med Chem; 2021 May; 64(10):6996-7032. PubMed ID: 33988379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The PPARδ agonist GW0742 inhibits neuroinflammation, but does not restore neurogenesis or prevent early delayed hippocampal-dependent cognitive impairment after whole-brain irradiation.
    Schnegg CI; Greene-Schloesser D; Kooshki M; Payne VS; Hsu FC; Robbins ME
    Free Radic Biol Med; 2013 Aug; 61():1-9. PubMed ID: 23499837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of Emphysema.
    Ozawa C; Horiguchi M; Akita T; Oiso Y; Abe K; Motomura T; Yamashita C
    Biol Pharm Bull; 2016; 39(5):778-85. PubMed ID: 27150147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of receptors δ (PPARδ) by agonist (GW0742) may enhance lipid metabolism in heart both in vivo and in vitro.
    Kuo SC; Ku PM; Chen LJ; Niu HS; Cheng JT
    Horm Metab Res; 2013 Nov; 45(12):880-6. PubMed ID: 23803968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity.
    Toral M; Gómez-Guzmán M; Jiménez R; Romero M; Zarzuelo MJ; Utrilla MP; Hermenegildo C; Cogolludo Á; Pérez-Vizcaíno F; Gálvez J; Duarte J
    J Hypertens; 2015 Sep; 33(9):1831-44. PubMed ID: 26147382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteins.
    Vittoria Simonini M; Polak PE; Boullerne AI; Peters JM; Richardson JC; Feinstein DL
    ASN Neuro; 2010 Jan; 2(1):e00025. PubMed ID: 20001953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-dependent effects of peroxisome proliferator-activated receptors β/δ agonist on systemic inflammation after haemorrhagic shock.
    Yin L; Busch D; Qiao Z; van Griensven M; Teuben M; Hildebrand F; Pape HC; Pfeifer R
    Cytokine; 2018 Mar; 103():127-132. PubMed ID: 28969938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.
    Malm T; Mariani M; Donovan LJ; Neilson L; Landreth GE
    J Neuroinflammation; 2015 Jan; 12():7. PubMed ID: 25592770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice.
    Matsushita Y; Ogawa D; Wada J; Yamamoto N; Shikata K; Sato C; Tachibana H; Toyota N; Makino H
    Diabetes; 2011 Mar; 60(3):960-8. PubMed ID: 21270242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring Solution Structures of Peroxisome Proliferator-Activated Receptor β/δ upon Ligand Binding.
    Schwarz R; Tänzler D; Ihling CH; Sinz A
    PLoS One; 2016; 11(3):e0151412. PubMed ID: 26992147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPARδ agonist GW0742 ameliorates Aβ1-42-induced hippocampal neurotoxicity in mice.
    An YQ; Zhang CT; Du Y; Zhang M; Tang SS; Hu M; Long Y; Sun HB; Hong H
    Metab Brain Dis; 2016 Jun; 31(3):663-71. PubMed ID: 26864581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta.
    Krämer DK; Al-Khalili L; Perrini S; Skogsberg J; Wretenberg P; Kannisto K; Wallberg-Henriksson H; Ehrenborg E; Zierath JR; Krook A
    Diabetes; 2005 Apr; 54(4):1157-63. PubMed ID: 15793256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo activation of peroxisome proliferator-activated receptor-delta protects the heart from ischemia/reperfusion injury in Zucker fatty rats.
    Yue TL; Nerurkar SS; Bao W; Jucker BM; Sarov-Blat L; Steplewski K; Ohlstein EH; Willette RN
    J Pharmacol Exp Ther; 2008 May; 325(2):466-74. PubMed ID: 18287212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing for GW501516 (cardarine) in human hair using LC/MS-MS and confirmation by LC/HRMS.
    Kintz P; Ameline A; Gheddar L; Raul JS
    Drug Test Anal; 2020 Jul; 12(7):980-986. PubMed ID: 32298044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor {delta} regulates inflammation via NF-{kappa}B signaling in polymicrobial sepsis.
    Zingarelli B; Piraino G; Hake PW; O'Connor M; Denenberg A; Fan H; Cook JA
    Am J Pathol; 2010 Oct; 177(4):1834-47. PubMed ID: 20709805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferation-activated receptor δ agonist GW0742 interacts weakly with multiple nuclear receptors, including the vitamin D receptor.
    Nandhikonda P; Yasgar A; Baranowski AM; Sidhu PS; McCallum MM; Pawlak AJ; Teske K; Feleke B; Yuan NY; Kevin C; Bikle DD; Ayers SD; Webb P; Rai G; Simeonov A; Jadhav A; Maloney D; Arnold LA
    Biochemistry; 2013 Jun; 52(24):4193-203. PubMed ID: 23713684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPARβ/δ-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes.
    Konttinen H; Gureviciene I; Oksanen M; Grubman A; Loppi S; Huuskonen MT; Korhonen P; Lampinen R; Keuters M; Belaya I; Tanila H; Kanninen KM; Goldsteins G; Landreth G; Koistinaho J; Malm T
    Glia; 2019 Jan; 67(1):146-159. PubMed ID: 30453390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactivity screening and mass spectrometric confirmation for the detection of PPARδ agonists that increase type 1 muscle fibres.
    Bovee TF; Blokland M; Kersten S; Hamers AR; Heskamp HH; Essers ML; Nielen MW; van Ginkel LA
    Anal Bioanal Chem; 2014 Jan; 406(3):705-13. PubMed ID: 24287635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Context-dependent regulation of endothelial cell metabolism: differential effects of the PPARβ/δ agonist GW0742 and VEGF-A.
    Faulkner A; Lynam E; Purcell R; Jones C; Lopez C; Board M; Wagner KD; Wagner N; Carr C; Wheeler-Jones C
    Sci Rep; 2020 May; 10(1):7849. PubMed ID: 32398728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy.
    Capozzi ME; McCollum GW; Savage SR; Penn JS
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4197-207. PubMed ID: 23716627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.